PROPERTIES OF A SELECTIVE KAPPA AGONIST, U-50,488H

被引：231

作者：

LAHTI, RA

VONVOIGTLANDER, PF

BARSUHN, C

机构：

来源：

关键词：

D O I：

10.1016/0024-3205(82)90132-1

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：2257 / 2260

页数：4

共 14 条

[1] NOVEL OPIATE BINDING-SITES SELECTIVE FOR BENZOMORPHAN DRUGS
CHANG, KJ
HAZUM, E
CUATRECASAS, P
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (07): : 4141 - 4145
[2] DYNORPHIN IS A SPECIFIC ENDOGENOUS LIGAND OF THE KAPPA-OPIOID RECEPTOR
CHAVKIN, C
JAMES, IF
GOLDSTEIN, A
[J]. SCIENCE, 1982, 215 (4531) : 413 - 415
[3] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[4] HIGH-AFFINITY BINDING OF [H-3]ETHYLKETOCYCLAZOCINE TO RAT-BRAIN HOMOGENATE
HARRIS, DW
SETHY, VH
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 66 (01) : 121 - 123
[5] ETHYLKETOCYCLAZOCINE-H-3 BINDING - LACK OF EVIDENCE FOR A SEPARATE KAPPA-RECEPTOR IN RATS CNS
HILLER, JM
SIMON, EJ
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 60 (04) : 389 - 390
[6] KOSTERLITZ HW, 1980, J PHYSL LOND, pP67
[7] CHRONIC NALOXONE RESULTS IN PROLONGED INCREASES IN OPIATE BINDING-SITES IN BRAIN
LAHTI, RA
COLLINS, RJ
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 51 (02) : 185 - 186
[8] MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517
[9] MCGILLIARD KL, 1978, J PHARMACOL EXP THER, V207, P494
[10] PIERCEY MF, 1982, LIFE SCI, V31